PMID- 10731648 OWN - NLM STAT- MEDLINE DCOM- 20000519 LR - 20220309 IS - 1010-7940 (Print) IS - 1010-7940 (Linking) VI - 17 IP - 2 DP - 2000 Feb TI - Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. PG - 134-9 AB - OBJECTIVE: The long-term outcome of patients with aortic bioprosthetic valves could be improved by decreasing the reoperative mortality rate. METHODS: Predictors of emergency reoperation and reoperative mortality were identified retrospectively in 172 patients who had the first bioprosthetic aortic valve replacement between 1975 and 1988 (mean age 46+/-13 years) and were subjected to replacement of the degenerated bioprostheses between 1978 and 1997 (mean age 56+/-14 years). Emergency reoperation had to be performed in 31 patients (18%). RESULTS: The operative mortality was 5.2% (9/172), 22.6% for emergency (odds ratio 11.17; 95%-confidence limit 4.33-28.85) and 1.4% for elective replacement of the degenerated aortic bioprosthesis (P<0.0001; OR=20.3). Patients who died at reoperation had higher transvalvular gradients before the primary aortic valve replacement (P=0.007), received smaller bioprostheses at the first operation (P=0.03), had later recurrence of symptoms after the first aortic valve replacement (P=0.04), a higher pre-reoperative New York Heart Association (NYHA) class (P=0.02), and a higher incidence of coronary artery disease (P=0.001) and pulmonary artery hypertension (P=0.009). Endocarditis before the primary aortic valve replacement (P=0.004), postoperative pneumonia at the first operation (P=0.005), pulmonary hypertension (P=0.0004) acquired during the interval, later recurrence of symptoms (P=0.04) after the first operation, a lower ejection fraction at the time of reoperation (P=0.03) and acute onset of bioprosthetic regurgitation (P=0.00002) were predictors for emergency surgery. Higher transvalvular gradients at the primary aortic valve replacement (P=0. 006), coronary artery disease (P=0.003) acquired during the interval, the need for concomitant coronary artery revascularization (P=0. 001), sex (P=0.02) and size (P=0.05) and type of the bioprostheses used (P=0.007) were incremental predictors for reoperative mortality which were independent of emergency surgery. CONCLUSIONS: Elective replacement of failed aortic bioprostheses is safe. Patients undergoing emergency reoperation have a considerably higher mortality. They can be identified by a history of native aortic valve endocarditis, higher transvalvular gradients at primary aortic valve replacement, smaller bioprostheses, and pulmonary hypertension or coronary artery disease acquired during the interval. A failing bioprosthesis must be replaced at its first sign of dysfunction. FAU - Vogt, P R AU - Vogt PR AD - Clinic for Cardiovascular Surgery and Cardiology, University Hospital, Ramistrasse 100, CH-8091, Zurich, Switzerland. paul.vogt@chi.usz.ch FAU - Brunner-LaRocca, H AU - Brunner-LaRocca H FAU - Sidler, P AU - Sidler P FAU - Zund, G AU - Zund G FAU - Truniger, K AU - Truniger K FAU - Lachat, M AU - Lachat M FAU - Turina, J AU - Turina J FAU - Turina, M I AU - Turina MI LA - eng PT - Journal Article PL - Germany TA - Eur J Cardiothorac Surg JT - European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery JID - 8804069 SB - IM MH - Aortic Valve MH - Aortic Valve Insufficiency/surgery MH - Aortic Valve Stenosis/surgery MH - *Bioprosthesis MH - Emergencies MH - Female MH - *Heart Valve Prosthesis MH - Heart Valve Prosthesis Implantation/mortality MH - Humans MH - Male MH - Middle Aged MH - Prosthesis Failure MH - Reoperation/mortality MH - Retrospective Studies EDAT- 2000/03/25 09:00 MHDA- 2000/06/08 09:00 CRDT- 2000/03/25 09:00 PHST- 2000/03/25 09:00 [pubmed] PHST- 2000/06/08 09:00 [medline] PHST- 2000/03/25 09:00 [entrez] AID - S1010794099003632 [pii] AID - 10.1016/s1010-7940(99)00363-2 [doi] PST - ppublish SO - Eur J Cardiothorac Surg. 2000 Feb;17(2):134-9. doi: 10.1016/s1010-7940(99)00363-2.